D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 80 Citations 22,422 291 World Ranking 318 National Ranking 1
Medicine D-index 92 Citations 32,380 436 World Ranking 5349 National Ranking 5

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Enzyme

His primary areas of study are Visceral leishmaniasis, Leishmaniasis, Immunology, Leishmania donovani and Miltefosine. His studies in Visceral leishmaniasis integrate themes in fields like Surgery, Internal medicine, Adverse effect, Combination therapy and Intensive care medicine. His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Chemotherapy, Nephrotoxicity, Oral administration and Indian visceral leishmaniasis.

His Leishmaniasis research is multidisciplinary, incorporating elements of Clinical trial, Pharmacology, Veterinary medicine, Leishmania and Drug resistance. The concepts of his Leishmania donovani study are interwoven with issues in Incidence, Virology, Amastigote, Microbiology and Molecular biology. His research in Miltefosine focuses on subjects like Dermatology, which are connected to Cutaneous leishmaniasis.

His most cited work include:

  • Drug Resistance in Leishmaniasis (1224 citations)
  • Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (1139 citations)
  • Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda (636 citations)

What are the main themes of his work throughout his whole career to date?

Shyam Sundar mainly investigates Visceral leishmaniasis, Leishmaniasis, Leishmania donovani, Immunology and Internal medicine. His Visceral leishmaniasis research is mostly focused on the topic Miltefosine. His study in Leishmaniasis is interdisciplinary in nature, drawing from both Chemotherapy, Serology, Direct agglutination test, Intensive care medicine and Veterinary medicine.

Shyam Sundar interconnects Molecular biology, Amastigote and Drug resistance, Microbiology in the investigation of issues within Leishmania donovani. His work carried out in the field of Immunology brings together such families of science as Peripheral blood mononuclear cell and Asymptomatic. His research combines Gastroenterology and Internal medicine.

He most often published in these fields:

  • Visceral leishmaniasis (54.77%)
  • Leishmaniasis (33.08%)
  • Leishmania donovani (31.38%)

What were the highlights of his more recent work (between 2017-2021)?

  • Visceral leishmaniasis (54.77%)
  • Leishmania donovani (31.38%)
  • Leishmaniasis (33.08%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Visceral leishmaniasis, Leishmania donovani, Leishmaniasis, Immunology and Leishmania. His study in the field of Miltefosine is also linked to topics like Indian subcontinent. His Leishmania donovani study combines topics in areas such as Immunity, Antigen, Microbiology, Intracellular and Pharmacology.

His Leishmaniasis research integrates issues from Xenodiagnosis, Intensive care medicine, Disease and Virology. The Leishmania study combines topics in areas such as Macrophage and Proteomics, Gene, Genome. His Internal medicine research is multidisciplinary, incorporating perspectives in Serology and Rapid diagnostic test.

Between 2017 and 2021, his most popular works were:

  • Eliminating visceral leishmaniasis in South Asia: the road ahead. (37 citations)
  • Current and emerging medications for the treatment of leishmaniasis (33 citations)
  • Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani. (26 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Drug Resistance in Leishmaniasis

Simon L. Croft;Shyam Sundar;Alan H. Fairlamb.
Clinical Microbiology Reviews (2006)

1810 Citations

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

François Chappuis;François Chappuis;Shyam Sundar;Asrat Hailu;Hashim Ghalib.
Nature Reviews Microbiology (2007)

1757 Citations

Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda

Philippe J Guerin;Philippe J Guerin;Piero Olliaro;Piero Olliaro;Shyam Sundar;Marleen Boelaert.
Lancet Infectious Diseases (2002)

983 Citations

Oral Miltefosine for Indian Visceral Leishmaniasis

Shyam Sundar;T K Jha;C P Thakur;Juergen Engel.
The New England Journal of Medicine (2002)

793 Citations

Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

Shyam Sundar;Deepak K. More;Manoj K. Singh;Vijay P. Singh.
Clinical Infectious Diseases (2000)

733 Citations

Drug resistance in Indian visceral leishmaniasis.

Shyam Sundar.
Tropical Medicine & International Health (2001)

718 Citations

Laboratory Diagnosis of Visceral Leishmaniasis

Shyam Sundar;M. Rai.
Clinical and Vaccine Immunology (2002)

677 Citations

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.

T.K. Jha;Shyam Sundar;C.P. Thakur;Peter Bachmann.
The New England Journal of Medicine (1999)

534 Citations

Injectable paromomycin for Visceral leishmaniasis in India.

Shyam Sundar;T.K. Jha;Chandreshwar P. Thakur;Prabhat K. Sinha.
The New England Journal of Medicine (2007)

465 Citations

Evidence that the High Incidence of Treatment Failures in Indian Kala-Azar Is Due to the Emergence of Antimony-Resistant Strains of Leishmania donovani

Rosalia Lira;Shyam Sundar;A. Makharia;Richard Kenney.
The Journal of Infectious Diseases (1999)

450 Citations

Best Scientists Citing Shyam Sundar

Jean-Claude Dujardin

Jean-Claude Dujardin

Institute of Tropical Medicine Antwerp

Publications: 140

Marleen Boelaert

Marleen Boelaert

Institute of Tropical Medicine Antwerp

Publications: 95

Simon L. Croft

Simon L. Croft

University of London

Publications: 76

Marc Ouellette

Marc Ouellette

Université Laval

Publications: 74

Mehdi Mohebali

Mehdi Mohebali

Tehran University of Medical Sciences

Publications: 69

Jorge Alvar

Jorge Alvar

Drugs for Neglected Diseases Initiative

Publications: 55

Steven G. Reed

Steven G. Reed

Infectious Disease Research Institute

Publications: 52

Paul M. Kaye

Paul M. Kaye

Hull York Medical School

Publications: 51

Greg Matlashewski

Greg Matlashewski

McGill University

Publications: 48

Petr Volf

Petr Volf

Charles University

Publications: 43

Abhay R. Satoskar

Abhay R. Satoskar

The Ohio State University

Publications: 41

Mary E. Wilson

Mary E. Wilson

University of Iowa

Publications: 40

Caryn Bern

Caryn Bern

University of California, San Francisco

Publications: 36

Ricardo T. Gazzinelli

Ricardo T. Gazzinelli

Universidade de São Paulo

Publications: 36

Hira L. Nakhasi

Hira L. Nakhasi

Center for Biologics Evaluation and Research

Publications: 35

Edgar M. Carvalho

Edgar M. Carvalho

Federal University of Bahia

Publications: 34

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.